TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05985889

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot
Description: You have to walk with a robot mounted on your lower limb. To move, to change direction.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fizio
Description: Patients do state-funded physical therapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXE1
Description: Patients undergo intensive virtual reality therapy once a day.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXE2
Description: Patients undergo intensive virtual reality therapy twice a day.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXE+ROB
Description: The patients intensively performed 1 virtual reality therapy and 1 robotic therapy every day.
Study: NCT06506227

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medium risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medium risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: High risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces + Specialized Inpatient Rehabilitation

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: High risk experimental group
Description: Guiding + Manipulation + Traditional Chinese Medicine + Specific Exercise Therapy + Orthopedic Braces + Specialized Inpatient Rehabilitation

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB 10-20°
Description: Specific Exercise Therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB 10-20°
Description: Specific Exercise Therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB 20-45°
Description: Orthopedic Braces + Specific Exercise Therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB 20-45°
Description: Orthopedic Braces + Specific Exercise Therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB >45°
Description: Orthopedic Braces + Specific Exercise Therapy + Recommended Surgery

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group COBB >45°
Description: Orthopedic Braces + Specific Exercise Therapy + Recommended Surgery

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group (AIS group)
Description: Molecular marker exploration and validation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group (AIS group)
Description: Molecular marker exploration and validation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control group (healthy control)
Description: Molecular marker exploration and validation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control group (healthy control)
Description: Molecular marker exploration and validation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled follow-up before and after AIS
Description: Construction and validation of AIS risk prediction model completed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled follow-up before and after AIS
Description: Construction and validation of AIS risk prediction model completed
Study: NCT05893173

Intervention type: BEHAVIORAL
Intervention: Sleep Deprivation
Description: Ten individuals (aged 18-85) with a DSM-V diagnosis of MDD will undergo baseline GluCEST imaging prior to and following approximately 30 hours of total sleep deprivation.
Study: NCT06697431

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Immunoglobulins, Human
Description: see previous section
Study: NCT06698445

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short film video
Description: The short film training video will be prepared by researchers based on literature and appropriate for the level of children aged 7-12. The content will include topics such as preparation for KİAB, KİAB environment and the process after KİAB. Since the short film will be shot in a realistic manner, the scenario will include a doctor, a nurse, a child patient and a parent. The short film will be shot in the clinic where the data will be collected, at the appropriate time for the clinic. After the short film is shot, the editing process will be done and the final version will be given.
Study: NCT06699147

Intervention type: DEVICE
Intervention: Hyaluronic Acid (HA)
Description: 6 types of hyaluronic acid(HA) fillers that are differ in HA concentration and lidocaine were used for this study. Each type was applied to different condition or group depending on the investigators medical diagnosis

Intervention type: DEVICE
Intervention: Hyaluronic Acid (HA)
Description: 6 types of hyaluronic acid(HA) fillers that are differ in HA concentration and lidocaine were used for this study. Each type was applied to different condition or group depending on the investigators medical diagnosis

Intervention type: DEVICE
Intervention: Hyaluronic Acid (HA)
Description: 6 types of hyaluronic acid(HA) fillers that are differ in HA concentration and lidocaine were used for this study. Each type was applied to different condition or group depending on the investigators medical diagnosis
Study: NCT05120297

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK101
Description: Subjects will receive AK101 subcutaneous injection at week 0 and week 4, and will follow up to week 16.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive placebo subcutaneous injection at week 0 and week 4, and will follow up to week 16.
Study: NCT04924647

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenalidomide and dexamethasone
Description: lenalidomide 25mg d1-21 and dexamethasone 20-40mg d1，8，15，22
Study: NCT04432662

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darbepoetin Alfa
Description: Administration of Darbepoetin Alpha (10 mcg/kg) IV x2 doses following cooling therapy.
Study: NCT05193656

Intervention type: DIAGNOSTIC_TEST
Intervention: Al_bladder
Description: Detection of bladder tumor with help of Artificial intelligence
Study: NCT05778747

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heart to Heart Yoga
Description: The Heart to Heart Yoga intervention is a therapeutic and standardized form of yoga intervention that is adapted from MediYoga designed to fit the needs of patients with HF and family caregivers who have physical limitations and depressive symptoms and to fit cultural and social norms in Kentucky. The intervention will use a gradual, physical/ psychological yoga adaptation approach, and it will be delivered two times per week (40 -60 minutes per session) via videoconference technology for 12 weeks (total 24 sessions). Real-time, face-to-face, video conferencing technology is used.
Study: NCT06700122

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: non-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D
Description: non-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: non-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D
Description: non-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D
Study: NCT06698484

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAR-T cells
Description: 2×10\^6 CAR T cells/kg
Study: NCT05379517

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed ectromagnetid field therapy
Description: Pulsed electromagnetic field therapy is an innovative therapy. The technology is based on a high intensity electromagnetic field, which positively influences human tissue. It is a form of non-invasive treatment, with good tolerance by patients. High-intensity electromagnetic fields excite neural and muscle cells, which stimulates the human body.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (PRP)
Description: This type of physiotherapy program includes: respiratory muscle training, coughing exercises, diaphragmatic training, aerobic training and strength training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (PRP)
Description: This type of physiotherapy program includes: respiratory muscle training, coughing exercises, diaphragmatic training, aerobic training and strength training.
Study: NCT04284735

Intervention type: OTHER
Group type: OTHER
Intervention: Quantitative ATX and LPA determination in plasma and sputum
Description: Determination of ATX and LPA levels in plasma and sputum from RA-ILD patients (cases) and in plasma and sputum from RA patients without ILD (controls) after sputum induction using hypertonic saline inhalation

Intervention type: OTHER
Group type: OTHER
Intervention: Quantitative ATX and LPA determination in plasma and sputum
Description: Determination of ATX and LPA levels in plasma and sputum from RA-ILD patients (cases) and in plasma and sputum from RA patients without ILD (controls) after sputum induction using hypertonic saline inhalation
Study: NCT06277986

Intervention type: OTHER
Intervention: cachexia
Description: Cachexia mainly manifests as weight loss. 1)weight loss \>5% over past 6 months. 2)BMI\<20 and any degree of weight loss \>2%. 3)Appendicular skeletal muscle index consistent with sarcopenia and any degree of weight loss \>2%.

Intervention type: OTHER
Intervention: cachexia
Description: Cachexia mainly manifests as weight loss. 1)weight loss \>5% over past 6 months. 2)BMI\<20 and any degree of weight loss \>2%. 3)Appendicular skeletal muscle index consistent with sarcopenia and any degree of weight loss \>2%.
Study: NCT06698627

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Daily Disposable Continence Device
Description: The Poise® Impressa® is an over-the-counter intravaginal device for women over the age of 21 years with SUI. It is a disposable, one-time use tampon-like device that comprises a core, cover, and applicator. The device is inserted and removed like a vaginal tampon and comes in three sizes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monthly Disposable Continence Device
Description: The Revive® is another over the counter vaginal insert for the treatment of SUI. This is a self-deployable, double-loop pessary device.
Study: NCT06698666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg tablet.
Description: The dose of rosuvastatin was derived from literature describing the doses at which the agents' targeted actions are effective and safe. The 10- mg rosuvastatin dose reflects the lowest prescribed therapeutic dose A serum cholesterol level will be drawn from the whole participants and sent to the central laboratories of El-Demerdash hospital at baseline and at week 12.~At each visit, participants will be requested to return all unused investigational products. Adherence to medication will be assessed by a pill count.

Intervention type: DRUG
Group type: OTHER
Intervention: Sertraline Pill
Description: Both control and intervention group will receive the sertraline as a standard therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sertraline Pill
Description: Both control and intervention group will receive the sertraline as a standard therapy
Study: NCT06700161

Intervention type: OTHER
Intervention: Obtaining CGF from patients
Description: Periodontal clinical parameters and Annexin and Lipoxin parameters in CGF will be compared between the test and control groups

Intervention type: OTHER
Intervention: Obtaining CGF from patients
Description: Periodontal clinical parameters and Annexin and Lipoxin parameters in CGF will be compared between the test and control groups
Study: NCT06698393

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suture 3.0 Group
Description: The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1 mm, 2 horizontal incisions of approximately 3 mm will be made at the base of the surgical papillae laterally to the recession.Two divergent releasing incisions will be made extending approximately 2-3 mm into the alveolar mucosa.The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of the crest bone.A partial thickness dissection will be performed in the most apical portion of the flap until complete passivation of the flap is obtained.The harvesting of the epithelial-connective graft will be performed at the la. The de-epithelialised graft will be sutured at the level of the de-epithelialised anatomical papillae.The flap will be repositioned coronally suturing the anatomical papillae on the surgical ones, using a Non-Resorbable Polyamide Suture of 3.0 Diameter.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suture 6.0 Group
Description: The extent of the depth of the recession will be reported on the anatomical papillae and, after adding 1 mm, 2 horizontal incisions of approximately 3 mm will be made at the base of the surgical papillae laterally to the recession.Two divergent releasing incisions will be made extending approximately 2-3 mm into the alveolar mucosa.The surgical papillae will be detached in partial thickness. A full thickness dissection will be performed from the bottom of the recession to expose approximately 3mm of the crest bone.A partial thickness dissection will be performed in the most apical portion of the flap until complete passivation of the flap is obtained.The harvesting of the epithelial-connective graft will be performed at the la. The de-epithelialised graft will be sutured at the level of the de-epithelialised anatomical papillae.The flap will be repositioned coronally suturing the anatomical papillae on the surgical ones, using a Non-Resorbable Polyamide Suture of 6.0 Diameter.
Study: NCT06522438

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA) and Octenidine gel
Description: A thermosensitive gel with Hyaluronic Acid (HA) and Octenidine (Pocket-X®, Geistlich, Wolhusen, Switzerland) will be applied in the periodontal pockets ≥5mm immediately after the subgingival PMPR, by means of a pre-filled syringe bearing a thin plastic tip and following manufacturer's instructions.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-surgical periodontal treatment (NSPT)
Description: Full mouth supragingival professional mechanical plaque removal (PMPR) and subgingival PMPR at sites with PPD ≥4mm will be performed with the aid of manual and power-driven instruments under local anaesthesia.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment (NSPT)
Description: Full mouth supragingival professional mechanical plaque removal (PMPR) and subgingival PMPR at sites with PPD ≥4mm will be performed with the aid of manual and power-driven instruments under local anaesthesia.
Study: NCT04784585

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Education
Description: The Enhanced Education intervention option seeks to: 1) enhance understanding of personal health-behavior links, 2) improve health literacy by checking the adequacy of participant understanding, and 3) remind participant of important elements of Behavioral Obesity Treatment (BOT) dietary goals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Efficacy
Description: This intervention option is based on a previously established self-efficacy intervention for weight loss, which is a multi-component intervention for increasing self-efficacy. To provide variety in this intervention option and limit time spent in a single intervention, components are split into independent modules that either prompt: 1) attainable intention setting related to dietary adherence (e.g., I will focus on eating mostly fruits/vegetables in my next meal/snack in order to take back control of my eating); 2) barrier identification for adhering to dietary goals along with a brief problem-solving exercise; 3) devising a small self-reward; OR 4) self-assessment of thoughts/behaviors that could interfere with dietary adherence in the next several hours with coping strategies (e.g., stimulus control, social support).
Study: NCT05629624

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chickpea based RUSF
Description: One group will receive locally produced RUSF, approximate at 50-100 kcal/kg/day, two of 50g packets daily (42) until anthropometric recovery ( WHZ \> - 1SD) has been achieved or for maximum 3 months then immediately 1 packet / day SQLNS will be given throughout the study till the end of 2 years of follow-up.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: E-RUSF
Description: The other group will receive the E-RUSF at 50-100 kcal/kg/day which in this age group approximates one 92 g sachet daily until anthropometric recovery ( WHZ \> - 1SD) has been achieved or for a of maximum 3 months, then immediately E-SQLNS 1 packet daily provided throughout the study till the end of 2 years of follow-up.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Outcome reference group/RUSF
Description: We will also recruit 70 three-year-old previously untreated MAM children WHZ \<-2 and ≥-3 z-score, and/or MUAC \<12.5 and ≥11.5 cm as an outcome reference group for a singular assessment. All children (both case \& control) will undergo a baseline nutritional, medical, biological and neuropsychological assessment (EF, ER, EEG and fNIRS). After all the assessments chick-pea based RUSF will be given for 2 months for nutritional rehabilitation.
Study: NCT05841251

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Phenylephrine Solution
Description: phenylephrine-soaked pack using the whole 5 ml of the solution provided with.5% phenylephrine will be applied after induction of surgery and intubation, 15 minutes before surgery. 100 ml of normal saline will be given.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous tranexamic acid
Description: patients will receive intravenous Single dose of tranexamic acid 15 mg/kg in 100 mL normal saline over 10 minutes. Saline-soaked pack will be applied.
Study: NCT05830201

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No Dog Present
Description: Dog is not present during pin removal

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dog is Present
Description: Dog is present during pin removal
Study: NCT05291247

Intervention type: DEVICE
Intervention: Peripheral lithotripsy system (Shockwave Medical)
Description: The combination of Shockwave Intravascular Lithotripsy and a polymer coated Drug Eluting Stent device for calcified femoropopliteal disease.
Study: NCT05424042

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: In-Person Caloric Restriction
Description: 20% CR delivered in-person by dietitian/coach

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote Caloric Restriction
Description: 20% reduction in caloric intake, meeting schedule, and physical activity goal delivered remotely.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted
Description: 8-hour TRE with ad libitum caloric intake. This group will undergo a 9-month dietary intervention targeting consumption of all daily caloric intake within an 8-hour window of time, with no restrictions on caloric intake.
Study: NCT04784585

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivation
Description: To provide variety in this intervention option and limit time spent in a single intervention, components are split into independent modules that either: 1) guide participants in identifying values related to weight control (e.g., longevity, quality of life, being a role model) and connect those values to their behavior in the current moment.; 2) use a collaborative non-judgmental approach to explore the consequences of letting barriers drive behavior (e.g., Take a moment to consider the effect on your longevity if you let your preference for sweets determine your behavior.); 3) prompt participants to identify reasons for change, thereby eliciting change talk; OR 4) engage participants in a brief self-assessment of motivation for dietary adherence (i.e., On a scale of 1-10, how important to you is it to stick to your dietary goals today).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Regulation
Description: There are 4 independent modules that prompt self-monitoring and self-awareness efforts: 1) advise participants to record everything that they eat before they eat it, with attention to eating in the subsequent few hours; 2) use the traffic light model to enhance awareness of dietary intake. This module provides the traffic light categories of foods (i.e., green=healthiest choices, yellow=sometimes choices, and red=rare choices), and asks participants to check-off foods that they intend to eat vs. stay away from in the next few hours; 3) advise participants to track portion sizes carefully and provide a portion size guide that is available to them until the following EMA survey; OR 4) provide a tutorial on noticing hunger/satiety cues and slowing down rate of eating, with an experiential exercise for use during their next eating episode.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Generic Risk Alert (Active Comparator)
Description: Participants will be notified that the JITAI algorithm has determined heightened lapse risk in the following 2-3 hours (i.e., We have detected that your risk of lapsing from your weight loss diet is higher than usual and may require attention.).
Study: NCT05160519

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Class IV Laser
Description: 30 participants will be irradiated with Class IV laser therapy over the left parasternal area to examine the efficacy of class IV laser on ejection fraction, Cardiac Biomarker and functional outcomes.~Device: Litecure LCT-1000C Class IV laser will be used in contact method over the left parasternal area in 2nd, 3rd intercostal space and apex. Dosage and Parameters for the irradiation will be calculated. Parameters: 1. Wavelength: 980nm, 2. Power/ Energy density: 6W/6J/cm2 3. Frequency: CW 4. Energy delivered at each spot: 360J 5. irradiation spots: 3 6. Irradiation time: 60 sec at each spot.~Both the patient and laser giver will use the laser protected eye wears to ensure standard practice for the laser.

Intervention type: RADIATION
Group type: SHAM_COMPARATOR
Intervention: Sham Class IV Laser
Description: 30 participants in sham control group will be suppose to irradiate with Class IV laser therapy over the left parasternal area, but the radiation will not be delivered.~Device: Litecure LCT-1000C Class IV laser will be placed over the left parasternal area in 2nd, 3rd intercostal space and apex without switching on the instrument.~Both the patient and laser giver will use the laser protected eye wears to ensure standard practice for the laser.